| abstract |
The invention relates to a probiotic strain selected from Lactobacillus reuteri V3401 with accession number CECT 8605 and Bifidobacterium brief BT820 with accession number CECT 8606, or a variant of said probiotic strain capable of absorbing cholesterol, and therapeutic methods and uses of the same. The invention also relates to compositions, pharmaceutical compositions, feed or nutritional products comprising a probiotic strain selected from Lactobacillus reuteri V3401 with accession number CECT 8605 and Bifidobacterium breve BT820 with accession number CECT 8606, or a variant of said probiotic strain with ability to absorb cholesterol. |